IV-delivered therapy for canine OA advances toward FDA approvalMay 7, 2026A study of intravenous uterine-derived mesenchymal stromal cells (UMSCs) in dogs with “naturally occurring OA” reportedly shows improvements in pain and mobility, with no serious treatment-related adverse events.
Education Center - SponsoredReclaiming Lost Hours: How Digital Prescription Management Is Reshaping Veterinary Workflowsby • MWI Animal HealthAs administrative burdens grow, digital prescription management offers veterinary teams a path to greater efficiency, fewer errors, and more time for patient care.
